Logo Image
News|Articles|January 31, 2020

In the Lab eNewsletter

  • Pharmaceutical Technology\'s In the Lab eNewsletter-02-05-2020
  • Volume 15
  • Issue 2

MilliporeSigma’s New Microbial Bioburden Testing System Offers Enhanced Results and Increased Productivity

The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.

MilliporeSigma’s latest innovation, the Milliflex Oasis System, offers enhanced benefits for pharmaceutical bioburden and water testing. It has 96 new features to increase result reliability and traceability while streamlining the bioburden testing workflow, the company reports.

The benefits of the new system include:

  • Operator-independent handling steps, improved touch-free membrane transfer with color-coded components for increased result reliability

  • 50% faster filtration time compared with previous product generation

  • Scalable hardware for high throughput

  • Reduced decontamination and maintenance time for optimized productivity

  • 2-dimensional codes and labels on primary and secondary packaging, on each funnel and media plate, for traceability and regulation compliance

The system also offers an all-in-one filtration solution with sterilized, ready-to-use filtration units and pharmacopeia-compliant media for comfort and peace of mind for water and bioburden testing, according to the company. MilliporeSigma launched the Milliflex Oasis System on Jan. 29, 2020.

Source: MilliporeSigma

Articles in this issue

over 6 years ago

Antibody Development Made Easier with Synthetic Biology

over 6 years ago

Evonetix, imec Partner on Chip-Based Technology Scale-Up

over 6 years ago

Daiichi Sankyo Licenses ERS Genomics’ CRISPR Gene Editing Tech

over 6 years ago

Otsuka, PhoreMost Team Up for Drug Discovery

over 6 years ago

Nicoya Introduces the First Digital Benchtop SPR System

over 6 years ago

Sierra Instruments Announces MEMS-Based Thermal Mass Flow Controllers and Meters

over 6 years ago

SP Scientific Launches HT Series 3i Evaporators

over 6 years ago

Vetter Combines Laboratory Portfolio into Single Site

almost 7 years ago

Finding the Source of Quality Problems

Related to this article

View more
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Power of Two One-Sided Tests with Unequal Variances
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Read more
Complying with International Pharmacopoeias
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Read more
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Read more
PharmTech Weekly Roundup—October 2, 2026
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Read more